Status:
COMPLETED
Special Drug Use Investigation for ALLERMIST (Long Term)
Lead Sponsor:
GlaxoSmithKline
Conditions:
Rhinitis
Eligibility:
All Genders
Brief Summary
This post-marketing surveillance study is to investigate possible problems or questions in safety and efficacy of ALLERMIST Nasal Spray for long-term use in Japanese subjects with allergic rhinitis un...
Eligibility Criteria
Inclusion
- Diagnosis of allergic rhinitis
- Use ALLERMIST for the first time
- Expected to use ALLERMIST for long-term (1 year).
Exclusion
- Subjects with infection which fluticasone is not effective
- Subjects with deep mycosis
- Subjects with hypersensitivity to fluticasone
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT01420822
Start Date
December 1 2010
End Date
August 1 2014
Last Update
March 27 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.